🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael P. Whyte

Shriners Hospitals for Children - Erie

ORCID: 0000-0002-8755-8490

Also affiliated with Shriners Hospitals for Children - St. Louis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK”.

Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK

Bone(2020)10.1016/j.bone.2020.115224
N/A
0DataRank · unranked
12 citations

Micol S. Rothman, Shenghui Duan, Jonathan C. Baker, Steven Mumm, Michael P. Whyte +1 more

Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V

Bone(2020)10.1016/j.bone.2020.115835
N/A
0DataRank · unranked
10 citations

James Aronson, William H. McAlister, Robert S. Weinstein, Deborah Wenkert, Karen L. Clements +9 more

Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia

Bone(2020)10.1016/j.bone.2020.115300
N/A
0DataRank · unranked
24 citations

Fan Zhang, Deborah Wenkert, Steven Mumm, Theresa J. Berndt, Rajiv Kumar +1 more

Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity

JBMR Plus(2022)10.1002/jbm4.10663
N/A
0DataRank · unranked
10 citations

Steven Mumm, Ceren Alavanda, Betul Sare Kaygusuz, Büşra Gürpınar Tosun, Ahmet Arman +6 more

Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

JBMR Plus(2024)10.1093/jbmrpl/ziad001
N/A
0DataRank · unranked
20 citations

Wolfgang Högler, Francis H. Glorieux, Anthony A. Portale, Michael P. Whyte, Craig F. Munns +16 more